Screener
Inhibrx Biosciences, Inc. INBX Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $133.34M-28.5% | $161.66M-25.3% | $124.22M-18.6% | $153.09M-22.0% | $186.57M-17.8% | ||
| $142.21M-26.7% | $171.34M-23.3% | $132.83M-17.2% | $161.42M-22.2% | $193.96M-19.9% | ||
| $2.69M-45.0% | $3.2M-42.4% | $3.73M-39.8% | $4.31M-37.4% | $4.89M-35.8% | ||
| $154.22M-27.3% | $183.97M-24.2% | $146.48M-19.0% | $177.47M-20.3% | $212.12M-17.9% | ||
| $9.8M+18.2% | $8.76M-1.5% | $5.94M-35.7% | $6.77M-45.2% | $8.29M-36.3% | ||
| $28.06M-27.9% | $26.51M-39.2% | $33.8M-17.0% | $35.98M-18.4% | $38.94M-0.3% | ||
| $176.29M+77.6% | $174.99M+77.4% | $100.56M— | $99.92M— | $99.28M— | ||
| $207.2M+44.3% | $205M+38.3% | $138.49M+194% | $140.64M+219% | $143.56M+268% | ||
| 120M0.0% | 120M0.0% | 120M+11,999,900% | 120M0.0% | 120M0.0% | ||
| -$316.28M-77.6% | -$279.63M-87.1% | -$246.19M-132% | -$213.35M-266% | -$178.1M-1,137% | ||
| -$52.98M-177% | -$21.04M-122% | $7.99M-94.0% | $36.83M-79.4% | $68.56M-68.7% | ||
| $154.22M-27.3% | $183.97M-24.2% | $146.48M-19.0% | $177.47M-20.3% | $212.12M-17.9% |
FAQ
- What are Inhibrx Biosciences, Inc.'s total assets?
- Inhibrx Biosciences, Inc. (INBX) holds $154.2M in total assets, down 27.3% year over year.
- How much debt does Inhibrx Biosciences, Inc. have?
- Inhibrx Biosciences, Inc. carries $181.6M in total debt against -$53.0M of shareholders' equity, a debt-to-equity ratio of 13.39.
- How much cash does Inhibrx Biosciences, Inc. have?
- Inhibrx Biosciences, Inc. holds $133.3M in cash and equivalents.
- Can Inhibrx Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 5.07 — current assets exceed current liabilities.
- Where does Inhibrx Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Inhibrx Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
